Psychiatry and Neurology, Neurology · New York, NY
NPI
1982871612
Since 2008
Specialty
Psychiatry and Neurology, Neurology
Code 2084N0400X
Group practices
1
Medicare group memberships
Hospitals
2
Hospital affiliations
535 E 70th St
New York, NY, 10021
Phone (212) 746-2584
Groups this clinician bills Medicare through
Medicare paid, 2024
$454K
28,064 services
Medicare patients, 2024
377
Average age 77
Drug cost, 2024
$2.2M
4,583 prescriptions
Company payments, 2025
$40K
From 7 companies
Procedures and visits billed to Original Medicare, 2024
In 2024, the most common Medicare service billed by Alexander Shtilbans was code J0585 (injection, onabotulinumtoxina, 1 unit), 19,928 times for 41 patients. In total Alexander Shtilbans billed 28,064 services in 34 codes, and Medicare paid $454K.
| Code |
|---|
Official US government data: the national provider registry and Medicare enrollment records, linked by NPI. Last update of this record: 2020-12-31.
| Setting |
|---|
| Services |
|---|
| Patients |
|---|
| Paid per service |
|---|
| Medicare paid |
|---|
| J0585 Injection, onabotulinumtoxina, 1 unit | Office | 19,928 | 41 | $4.94 | $98K |
| J1569 Injection, immune globulin, (gammagard liquid), non-lyophilized, (e.g., liquid), 500 mg | Office | 5,560 | 11 | $35.09 | $195K |
| 99215 Office E&M - Established | Office | 425 | 234 | $147.28 | $63K |
| 96366 Intravenous Infusion, Hydration | Office | 277 | 14 | $18.13 | $5,021 |
| 99214 Office E&M - Established | Office | 250 | 166 | $106.81 | $27K |
| 99213 Office E&M - Established | Office | 91 | 42 | $80.06 | $7,285 |
| 95874 Musculoskeletal | Office | 78 | 26 | $68.27 | $5,325 |
| 64616 Musculoskeletal | Office | 65 | 21 | $173.64 | $11K |
| 99205 Office E&M - New | Office | 61 | 61 | $184.40 | $11K |
| 96365 Intravenous Infusion, Hydration | Office | 60 | 14 | $56.92 | $3,415 |
| 99204 Office E&M - New | Office | 13 | 13 | $121.61 | $1,581 |
By year: 2022 $364K for 22,056 services; 2023 $380K for 24,780 services; 2024 $454K for 28,064 services.
Medicare prescription drug claims, 2024
In 2024, the drug Alexander Shtilbans prescribed most often to Medicare patients was Carbidopa-Levodopa (Carbidopa/Levodopa), with 883 prescriptions and refills. In total Alexander Shtilbans wrote 4,583 Medicare prescriptions that cost $2.2M.
| Drug | Claims | 30-day fills | Patients | Cost |
|---|---|---|---|---|
| Carbidopa-Levodopa Carbidopa/Levodopa | 883 | 1,645 | 198 | $23K |
| Carbidopa-Levodopa Er Carbidopa/Levodopa | 463 | 793 | 108 | $16K |
| Rytary Carbidopa/Levodopa | 395 | 500 | 50 | $442K |
| Propranolol Hcl Generic | 232 | 443 | 61 | $4,185 |
| Selegiline Hcl Generic | 172 | 284 | 28 | $14K |
| Mirtazapine Generic | 149 | 209 | 30 | $1,970 |
| Primidone Generic | 136 | 289 | 34 | $2,693 |
| Amantadine Amantadine Hcl | 132 | 224 | 29 | $5,941 |
| Rasagiline Mesylate Generic | 123 | 234 | 27 | $17K |
| Clonazepam Generic | 105 | 113 | 26 | $468 |
| Neupro Rotigotine | 105 | 145 | 18 | $116K |
| Nourianz Istradefylline | 102 | 192 | 26 | $359K |
| Nuplazid Pimavanserin Tartrate | 97 | 103 | 15 | $516K |
| Gabapentin Generic | 90 | 115 | 24 | $1,523 |
| Topiramate Generic | 82 | 140 | 18 | $1,452 |
Brand drugs: 1,069 claims; generic drugs: 3,514 claims; opioid claims: 54.
Money and other things of value reported by the companies
In 2025, drug and medical device companies paid Alexander Shtilbans $40K ($40K in general payments such as food, travel and fees) from 7 companies. The largest payer was Amneal Pharmaceuticals LLC with $20K.
Official US government data on Original Medicare services, Medicare prescription drug plans and the payments drug and device companies must report. Services with fewer than 11 patients and drugs with fewer than 11 claims are not published. Procedure codes are shown by number with their public category.